Todd Franklin Watanabe - Jun 6, 2022 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role: President and CEO, Director
Signature: /s/ Scott Burrows, as Attorney-in-Fact for Todd Franklin Watanabe
Stock symbol: ARQT
Transactions as of: Jun 6, 2022
Transactions value $: -$21,064
Form type: 4
Date filed: 6/6/2022, 04:06 PM
Previous filing: May 5, 2022
Next filing: Jul 7, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARQT	Common Stock	Sale	-$21.1K	-1K	-0.15%	$21.06	659K	Jun 6, 2022	Direct	F1, F2, F3, F4
holding	ARQT	Common Stock						57.4K	Jun 6, 2022	By LLC	F5
holding	ARQT	Common Stock						17.9K	Jun 6, 2022	By Trust	F6
holding	ARQT	Common Stock						17.9K	Jun 6, 2022	By Trust	F7
holding	ARQT	Common Stock						125K	Jun 6, 2022	By Trust	F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2	The transaction was executed in multiple trades in prices ranging from $20.84 to $21.50, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3	Reflects the adjusted total which includes the purchase of 1,617 shares under the Arcutis Employee Stock Purchase Plan on May 31, 2022.
F4	Includes 109,925 restricted stock units.
F5	The securities are held of record by Watanabe Ventures, LLC, of which the Reporting Person is the Chief Operating Officer. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
F6	The securities are held of record by The Anderson Prest Watanabe Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
F7	The securities are held of record by The John Franklin Watanabe Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
F8	The securities are held of record by The Watanabe 2016 Irrevocable Trust, of which the Reporting Person's children are beneficiaries. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.